Fortitude Advisory Group’s Clorox CLX Stock Holding History

Fortitude Advisory Group’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-595	Closed	-$83K	–	409
2022 Q1	$83K	Buy	595 +492	+478%	+$75.4K	0.04%	387
2021 Q4	$17K	Buy	+103	New	+$17.2K	0.01%	882

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fortitude Advisory Group's CLX Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Clorox (CLX) in Q2 2022, closing a stake of 595 shares — an estimated $83K sold.

Fortitude Advisory Group first reported a position in CLX in Q4 2021 and held it in 2 quarters. The position peaked at $83K in Q1 2022. 1,081 funds tracked by Wall St. Rank hold CLX as of Q2 2022.

Fortitude Advisory Group reported no remaining Clorox position as of Q2 2022 after selling out during the quarter.
Fortitude Advisory Group sold 595 Clorox shares in Q2 2022, an estimated $83K.
Fortitude Advisory Group first reported a position in Clorox in Q4 2021 and held it in 2 quarters.
Fortitude Advisory Group's Clorox position peaked at $83K in Q1 2022.
1,081 funds tracked by Wall St. Rank held Clorox as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.